SYN Insider Trading Activity and SEC Form 4 Filings
SYN insider trading summary
No open-market insider purchases or sales of Synthetic Biologics, Inc. (SYN) have been reported on SEC Form 4 in the past 12 months.
Latest SYN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 10, 2021 | Steven A Shallcross | CEO and CFO | Buy | $25K (50,000 @ $0.49) |
| Aug 23, 2019 | Steven A Shallcross | CEO and CFO | Buy | $21K (50,000 @ $0.42) |
| Apr 3, 2019 | Randal J Kirk | 10% Owner | Sell | $45K (69,161 @ $0.65) |
| Apr 3, 2019 | Intrexon Corp | 10% Owner | Sell | $17K (26,080 @ $0.65) |
| Apr 3, 2019 | Intrexon Corp | 10% Owner | Sell | $45K (69,161 @ $0.65) |
| Apr 3, 2019 | Randal J Kirk | 10% Owner | Sell | $17K (26,080 @ $0.65) |
| Apr 2, 2019 | Intrexon Corp | 10% Owner | Sell | $7K (9,909 @ $0.66) |
| Apr 2, 2019 | Randal J Kirk | 10% Owner | Sell | $7K (9,909 @ $0.66) |
| Apr 2, 2019 | Intrexon Corp | 10% Owner | Sell | $2K (3,737 @ $0.66) |
| Apr 2, 2019 | Randal J Kirk | 10% Owner | Sell | $2K (3,737 @ $0.66) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.